CN103041192B - Bedsore paste - Google Patents
Bedsore paste Download PDFInfo
- Publication number
- CN103041192B CN103041192B CN201210546767.5A CN201210546767A CN103041192B CN 103041192 B CN103041192 B CN 103041192B CN 201210546767 A CN201210546767 A CN 201210546767A CN 103041192 B CN103041192 B CN 103041192B
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- rhizoma
- bedsore
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000004210 Pressure Ulcer Diseases 0.000 title claims abstract description 33
- 239000003814 drug Substances 0.000 claims abstract description 7
- 229940079593 drug Drugs 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims abstract description 4
- 239000002674 ointment Substances 0.000 claims description 15
- 244000293323 Cosmos caudatus Species 0.000 claims description 3
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 3
- 235000000885 Garcinia xanthochymus Nutrition 0.000 claims description 3
- 244000153234 Hibiscus abelmoschus Species 0.000 claims description 3
- 241000237636 Pheretima Species 0.000 claims description 3
- 241001446509 Psoralea Species 0.000 claims description 3
- 239000007765 cera alba Substances 0.000 claims description 3
- 229940056582 human hair preparation Drugs 0.000 claims description 3
- 239000009286 sanguis draxonis Substances 0.000 claims description 3
- 244000119461 Garcinia xanthochymus Species 0.000 claims 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 abstract 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 240000000031 Achyranthes bidentata Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000546193 Clusiaceae Species 0.000 abstract 1
- 241000402754 Erythranthe moschata Species 0.000 abstract 1
- 241000305491 Gastrodia elata Species 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 241000219100 Rhamnaceae Species 0.000 abstract 1
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 abstract 1
- 229960000282 metronidazole Drugs 0.000 abstract 1
- 230000001114 myogenic effect Effects 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 229940045860 white wax Drugs 0.000 abstract 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 14
- 208000025865 Ulcer Diseases 0.000 description 9
- 231100000397 ulcer Toxicity 0.000 description 9
- 230000000694 effects Effects 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000593508 Garcinia Species 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241000545442 Radix Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A bedsore paste comprises the following raw material medicines in terms of weight: 10 g of root of oriental buckthorn, 10 g of gastrodia elata, 10 g of rhizoma acori graminei, 10 g of fructus psoraleae, 10 g of metronidazole, 10 g of alums, 10 g of earthworm, 10 g of angelica sinensis, 10 g of white wax, 10 g of dragon's blood, 10 g of rhizoma coptidis, 10 g of pearl powder, 10 g of borneol, 10 g of achyranthes bidentata, 10 g of clusiaceae, 10 g of radix salicis babylonicae, 10 g of polygonum cuspidatum, 10 g of carbonized hair, 10 g of apiary, 10 g of musk and 10 g of fructus gleditsiae abnormalis. The bedsore paste provided by the invention has the advantages of good sore healing and myogenic effects and quick action.
Description
technical field
The present invention relates to Chinese medicine technical field, particularly a kind of band bed sore ointment.
background technology
(the national pressure ulcer advisory panel of American National pressure ulcer advisor group, NPUAP) to the definition of pressure ulcer, be " pressure ulcer is to be confined to skin or hypodermic infringement; be often positioned at skeleton protruding part, relevant with pressure, friction and (or) shearing force ".Because most of pressure ulcer is preventible, so domestic, have health organ by it index as medical and nursing quality height, in management review standard, requiring situation of all-level hospitals patient's the number that occurs in pressure ulcer year is zero, but reality seldom has hospital can reach this standard.Because in specific crowd, pressure ulcer has the necessity of its generation, and treatment difficulty.The statistical data demonstration of the U.S. in 2004, the patient of concurrent pressure ulcer accounts for 14%～17% of inpatient, and the sickness rate of European inpatient pressure ulcer accounts for 18.1% of inpatient.Pressure ulcer not only brings misery to patient, also affects the recovery of primary disease, extends the hospital stays, increases hospitalization cost, even causes health to worsen or death.Pressure ulcer is the common difficulty that world health health institution faces.
Decubital ulcer, claims again pressure ulcer, bed-sore, pressure ulcer, is due to the long-term pressurized of local organization, and skin is for hypoxgia, generation continuous ischemia, anoxia, the necrosis of malnutrition Er Zhi tissue fester.Skin decubital ulcer is the problem of a universality in rehabilitation, nursing.At present clinical treatment is mainly that anti-inflammation is main, prevents secondary infection, but regeneration does not have good way for muscular tissue, because the granulation promoting open sore part that heals rapidly, so clinical efficacy is unsatisfactory.
Also have on the market now a lot of special ointment for pressure ulcer, its composition is mostly that therapeutic effect is not very satisfactory with medical materials such as the Radix Astragali, Fructus Forsythiae, Radix Angelicae Sinensis, the Radixs Angelicae Dahuricae.
summary of the invention
In order solving in above prior art, to treat the undesirable problem of decubital ulcer effect, to the invention provides a kind of effective band bed sore ointment of decubital ulcer for the treatment of.
The present invention is achieved by the following measures:
A band bed sore ointment, crude drug weight proportion is as follows:
10 grams of Radix rhamni crenataes, 10 grams, Rhizoma Gastrodiae, 10 grams of Rhizoma Acori Graminei, 10 grams of Fructus Psoraleaes, 10 grams of metronidazoles, 10 grams, Alumen, 10 grams of Pheretimas, 10 grams of Radix Angelicae Sinensis, 10 grams of white beeswax, 10 grams of Sanguis Draxonis, 10 grams of Rhizoma Coptidis, 10 grams of Margarita powder, 10 grams of Borneolum Syntheticums, 10 grams of Radix Achyranthis Bidentataes, 10 grams of Resina garciniaes, 10 grams of Radix Salicis Babylonicae, 10 grams of Rhizoma Polygoni Cuspidati, 10 grams of Crinis Carbonisatus, 10 grams, Nidus Vespae, 10 grams, Moschus, 10 grams of Fructus Gleditsiae Abnormalis.Described band bed sore ointment obtains by following steps:
(1) crude drug is added to the water, 2-3cm in the water that submerges, soaks half an hour, decocts 2-3 hour, and filtering residue adds the water of 5 times of weight again, decocts 1-2 hour, merging filtrate, and being concentrated into 50 ℃ of relative densities is 1.2-1.3, obtains concentrated solution and get final product.
Beneficial effect of the present invention: band bed sore ointment of the present invention, expelling pus and promoting granulation is effective, and instant effect is used and just takes effect for 2 days, uses medicament categories few, and preparation is simple, and easy to use, effective, effective percentage reaches 100%, is the first-selection of vast patients with bedsore.
The specific embodiment
For a better understanding of the present invention, below in conjunction with specific embodiment, further illustrate.
A band bed sore ointment, crude drug weight proportion is as follows: 10 grams of Radix rhamni crenataes, 10 grams, Rhizoma Gastrodiae, 10 grams of Rhizoma Acori Graminei, 10 grams of Fructus Psoraleaes, 10 grams of metronidazoles, 10 grams, Alumen, 10 grams of Pheretimas, 10 grams of Radix Angelicae Sinensis, 10 grams of white beeswax, 10 grams of Sanguis Draxonis, 10 grams of Rhizoma Coptidis, 10 grams of Margarita powder, 10 grams of Borneolum Syntheticums, 10 grams of Radix Achyranthis Bidentataes, 10 grams of Resina garciniaes, 10 grams of Radix Salicis Babylonicae, 10 grams of Rhizoma Polygoni Cuspidati, 10 grams of Crinis Carbonisatus, 10 grams, Nidus Vespae, 10 grams, Moschus, 10 grams of Fructus Gleditsiae Abnormalis.
Using method: band bed sore ointment is smeared in bedsore wound, smeared 50g ointment for every square centimeter, change dressings once every day.
clinical effectiveness checking
Choose patients with bedsore 50 examples, 122 of total decubital ulcers, fill in questionnaire by special messenger, and detailed medical history-taking, through health check-up comprehensively, all without complication such as septicemia.
According to patient's decubital ulcer by stages and the order of severity mark, be divided into two groups, treatment group and matched group, the decubital ulcer overall score result no difference of science of statistics of selected two groups.
Therapeutic Method:
1, treatment group: treat according to the band bed sore ointment using method of the present invention of embodiment 1, according to a course for the treatment of of first quarter moon, treat, until recovery from illness.
2, matched group: according to traditional Therapeutic Method iodophor disinfection, heat lamp is roasting, and dry the drying in the air of the open sore part will not be wrapped up, transfusion and supporting treatment.
All cases is observed two months, and result is as following table.
| Group | Decubital ulcer quantity | Cure quantity | Effective quantity | Effective quantity | Invalid quantity | Total effective rate |
| Treatment group | 61 | 44 | 16 | 1 | 0 | 100﹪ |
| Matched group | 61 | 25 | 17 | 7 | 12 | 80﹪ |
Conclusion: experiment shows, the therapeutic outcome of two groups has more significant difference, cure rate particularly, this band bed sore ointment reaches 72 ﹪, and the cure rate of matched group only has 41 ﹪, the total effective rate of decubital ulcer of the present invention reaches 100%, and matched group only has 80%, illustrate that band bed sore ointment of the present invention is greatly improved than traditional remedies in curative effect, has good therapeutic effect clinically.The patient who uses ointment of the present invention, without any untoward reaction, illustrates without any side effects.
Claims (1)
1. a band bed sore ointment, is characterized in that crude drug weight proportion is as follows:
10 grams of Radix rhamni crenataes, 10 grams, Rhizoma Gastrodiae, 10 grams of Rhizoma Acori Graminei, 10 grams of Fructus Psoraleaes, 10 grams of metronidazoles, 10 grams, Alumen, 10 grams of Pheretimas, 10 grams of Radix Angelicae Sinensis, 10 grams of white beeswax, 10 grams of Sanguis Draxonis, 10 grams of Rhizoma Coptidis, 10 grams of Margarita powder, 10 grams of Borneolum Syntheticums, 10 grams of Radix Achyranthis Bidentataes, 10 grams of Resina garciniaes, 10 grams of Radix Salicis Babylonicae, 10 grams of Rhizoma Polygoni Cuspidati, 10 grams of Crinis Carbonisatus, 10 grams, Nidus Vespae, 10 grams, Moschus, 10 grams of Fructus Gleditsiae Abnormalis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210546767.5A CN103041192B (en) | 2012-12-17 | 2012-12-17 | Bedsore paste |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210546767.5A CN103041192B (en) | 2012-12-17 | 2012-12-17 | Bedsore paste |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103041192A CN103041192A (en) | 2013-04-17 |
| CN103041192B true CN103041192B (en) | 2014-07-30 |
Family
ID=48054203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210546767.5A Expired - Fee Related CN103041192B (en) | 2012-12-17 | 2012-12-17 | Bedsore paste |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103041192B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103251754A (en) * | 2013-05-22 | 2013-08-21 | 孙胜波 | Traditional Chinese medicine composition for treating bedsore |
| CN109248253A (en) * | 2018-11-30 | 2019-01-22 | 李东 | A kind of Chinese medicine composition and preparation method thereof for treating various wounds |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1511560A (en) * | 2002-12-30 | 2004-07-14 | 常文清 | Method for producing bed sore ointment |
| CN102688383A (en) * | 2011-12-21 | 2012-09-26 | 河南科技大学 | Traditional Chinese medicine composite for treating body surface ulcer or fester |
| CN102755528A (en) * | 2011-04-24 | 2012-10-31 | 孙逊 | External Chinese medicine for treating bedsore |
-
2012
- 2012-12-17 CN CN201210546767.5A patent/CN103041192B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1511560A (en) * | 2002-12-30 | 2004-07-14 | 常文清 | Method for producing bed sore ointment |
| CN102755528A (en) * | 2011-04-24 | 2012-10-31 | 孙逊 | External Chinese medicine for treating bedsore |
| CN102688383A (en) * | 2011-12-21 | 2012-09-26 | 河南科技大学 | Traditional Chinese medicine composite for treating body surface ulcer or fester |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103041192A (en) | 2013-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102091202B (en) | A Chinese medicinal composition for treating fracture, and its preparation method | |
| CN103432534B (en) | Traditional Chinese prescription for treating hyperplasia of mammary glands | |
| CN101569672A (en) | Golden brain powder | |
| CN102657785B (en) | Medicinal composition for treating gingivitis | |
| CN103041192B (en) | Bedsore paste | |
| CN101513483B (en) | Rhizoma cibotii and eucommia bark soup used for curing protrusion of lumbar intervertebral disc | |
| CN101249184B (en) | Medicine for treating osteoproliferation as well as its preparation method | |
| CN103393999A (en) | Anti-inflammatory resolutive liquid medicine for promoting blood circulation to arrest pain | |
| CN102526385B (en) | Medicament for treating climacteric syndrome | |
| CN102283972B (en) | Pharmaceutical composition for treating rib fracture | |
| CN102274362B (en) | Plaster for treating mastopathy and preparation method thereof | |
| CN103341100A (en) | Medicinal liquor for activating blood, relieving pain, resisting inflammation and diminishing swelling | |
| CN102764421B (en) | Pressure ulcer ointment | |
| CN105311473A (en) | Rapid hemostasis drug | |
| CN101979073A (en) | Medicament for soothing liver and regulating Qi | |
| CN102579789B (en) | Medicine for treating eczema | |
| CN105582187B (en) | A Chinese medicinal composition for preventing and treating allergic dermatoses | |
| CN103316291A (en) | Anti acne of traditional Chinese medicine | |
| CN103550460A (en) | Traditional Chinese medicine formula for treatment of dysmenorrhoea | |
| CN103055051B (en) | Liquid for treating burn and scald | |
| CN1883642A (en) | Medicine for treating mammary glands hyperplasia | |
| CN102784291B (en) | A kind of liniment for the treatment of toothache with asthenic yin | |
| CN105727096A (en) | Medicine for treating onychomycosis | |
| CN102908392B (en) | External Chinese herbal preparation for treating nasal polyp and preparation method | |
| CN103157042B (en) | Medicament for treating Barrett syndrome |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: QINGDAO WINCHANCE TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: QINGDAO HAIYANG NEW MATERIAL SCIENCE AND TECHNOLOGY CO., LTD. Effective date: 20140619 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 266101 QINGDAO, SHANDONG PROVINCE TO: 266061 QINGDAO, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20140619 Address after: 266061 Shandong, Laoshan, Hongkong East Road, No. Pioneering Park, biological park, room 248, No. 239 Applicant after: Qingdao Wenchuang Science & Technology Co., Ltd. Address before: 266101 Zhuzhou Road, Laoshan District, Shandong, No. 143, No. Applicant before: Qingdao Advanced Marine Material Technology Co., Ltd. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Hu Shiqing Inventor before: Liu Lianhe |
|
| COR | Change of bibliographic data | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20160808 Address after: 69 No. three, Hu Hu Road, Chengguan Town, Qiannan Buyi and Miao Autonomous Prefecture, Guizhou 558000, China Patentee after: Guizhou husandie Pharmaceutical Co., Ltd. Address before: 266061 Shandong, Laoshan, Hongkong East Road, No. Pioneering Park, biological park, room 248, No. 239 Patentee before: Qingdao Wenchuang Science & Technology Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140730 Termination date: 20181217 |